Research Article

Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 Patients

Table 2

Types of coagulation disorders and treatment outcomes in patients with cirrhosis and splenomegaly.

GroupNumber of coagulation disordersTypes of coagulation disordersNumber of patients, (%)Treatment results
Effective, (%)Dead, (%)

1OnePT (>15 s)1241222 (1.6)
APTT (>40 s)41410 (0.0)
FIB (<2 g/L)30528916 (5.2)
TT (>21 s)36342 (5.6)
Subtotal506 (41.3)486 (96.0)20 (4.0)

2TwoPT+APTT93894 (4.3)
PT+PTA68653 (4.4)
PT+FIB91856 (6.6)
PT+TT16151 (6.3)
FIB+APTT880
FIB+TT880
APTT+TT330
Subtotal287 (23.4)273 (95.1)14 (4.9)

3Three or morePT+APTT+FIB30273 (10.0)
PT+FIB+TT770
PT+APTT+TT+PTA651 (16.6)
FIB+APTT+TT550
PT+APTT+FIB+PTA2352305 (2.1)
PT+FIB+APTT+TT981 (11.1)
PT+FIB+APTT+TT14013010 (7.1)
Subtotal432 (35.3)412 (95.8)20 (4.6)

Abbreviations: APTT: activated partial thromboplastin time; Fib: fibrinogen; PT: prothrombin time; PTA: prothrombin activity; TT: thrombin time.